Prognostic value of right ventriclediameter, pulmonary arterial pressure and biomarkers in patients with acute heart failure
Abstract
Objective: To examine the echocardiographic parameters of right ventricle (RV), its diameter and pulmonary arterial pressure (PAP); to determine their relationship to B-type natriuretic peptide (BNP), Troponin I (TnI) and high-sensititity C-raective protein (hsCRP), and to evaluate their prognostic significance to one-year mortality in patients with acute heart failure (AHF).
Material and Methods: The study included a total of 225 patients (pts) (70.29±9.74 years) who were admitted to Intensive care unit due to the signs and symptoms of AHF. The values of standard biochemical parameters,BNP, TnI and hsCRP were determined during the first 24 hours after admission. All patients underwent echocardiographic examination.
Results: During the one-year follow-up, 78 (34.70%) pts died. As compared with the group of survivors (n=147), the group of non-survivors had higher values of BNP (853.10±384.92 vs. 1399.68±464.44pg/mL, p<0.001), TnI (0.59±2.04 vs. 2.00±8.29 ng/ml, p<0.05), right ventricular diameter and PAP (p<0.001). BNPwas positively correlated with TnI (ρ=0.311), PAP (ρ=0.255) and right ventricular diameter (ρ=0.304, p<0.001 for all correlations). The cut-off value of BNP≥1062.04 pg/ml, PAP≥44.5 mmHg and TnI≥0.04 ng/ml were associated with a higher risk of mortality.
Conclusion: Our results have shown that BNP, PAP and TnI are strong and independent predictors of one-year mortality in hospitalized patients with acute heart failure.
References
2. Petrovic D, Deljanin Ilić M, Stojanović S. Prognostic value of biomarkers and co-morbidities in patients with acute heart failure: one-year follow-up study. Srp Arh Celok Lek 2017; 145(3-4):118-123.
3. Maggioni A, DahlströmU, FilippatosG, et al. EURObservational Research Programme: regional differences and 1-year follow-up results of theHeart Failure Pilot Survey (ESC-HF Pilot). European Heart Journal2013; 15: 808–817.DOI: 10.1093/eurjhf/hft050
4. Hobbs FDR, Jones MI, Allan TF, et al. European survey of primary care physician perceptions on heart failure diagnosis and management (Euro-F). Eur Heart J 2000;21:1877–1887. DOI: 10.1053/euhj.2000.2170
5.Mueller C, Scholer A, Laule-Kilian K, et al.Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004;350:647–54.DOI: 10.1056/NEJMoa031681
6.Harjola VP, Follath F, Nieminen MS, et al.Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure. Eur J Heart Fail 2010;12:239–48. DOI: 10.1093/eurjhf/hfq002
7.Kenneth D, Gerasimos F, Piotr P, et al. ESC guidelines for the diagnosis and treatment of acute and chronic Heart Failure 2008. European J of Heart Failure 2008;10:933-989.
DOI:10.1016/j.ejheart.2008.08.005
8.Mendes LA, Dec GW, Picard MH, et al.Right ventricular dysfunction: an independent predictor of adverse outcome in patients with myocarditis. Am Heart J. 1994; 128: 301–307. DOI: 10.1016/0002-8703(94)90483-9
9.ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal 2012; 33:1787–1847. DOI: 10.1093/eurheartj/ehs104
10.Lang RM, Badano LP, Mor-Avi V, et al.Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015;16:233–270. DOI: 10.1093/ehjci/jev014
11. Petrovic D, Deljanin Ilic M, Ilic S, at al. Prognostic significance of B-type natriuretic peptide and pulmonary arterial pressure in patients with acute heart failure. European Journal of Heart Failure 2017; 19 (Suppl. S1): 392-392.
12.Siirila-Waris K, Lassus J, Melin J, et al.Characteristics, outcomes, and predictors of 1-yearmortality in patients hospitalized for acute heart failure. Eur Heart J 2006;27:3011–3017. DOI: 10.1093/eurheartj/ehl407
13.Bosseau C, Galli E, Donal E. Prognostic value of BNP in heart failure with preserved or reduced EF. Heart 2015; 101(23): 1855-6. DOI:10.1136/heartjnl-2015-308515.
14.Peacock WF, De Marco T, Fonarow GC, et al.Cardiac troponin and outcome in acute heart failure. N Engl J Med 2008; 358(20): 2117-2126. DOI: 10.1056/NEJMoa0706824
15.Araújo JP, Lourenço P, Azevedo A. Prognostic value of high-sensitivity C-reactive protein in heart failure: a systematic review. J Card Fail 2009; 15:256–266.
DOI: 10.1016/j.cardfail.2008.10.030
16.O'Connor CM, Stough WG, Gallup DS, et al.Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry. J Card Fail 2005;11(3):200-205. DOI: 10.1016/j.cardfail.2004.08.160
17. Burke MA, Katz DH, Beussink L, et al.Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction.Circ Heart Fail. 2014;7(2):288-99.DOI: 10.1161/CIRCHEARTFAILURE.113.000854
18. Vincent FMS, Dirk LB, Gilles WDeK. Pulmonary hypertension and right heart failure in heart failure with preserved left ventricular ejection fraction: pathophysiology and natural history.Curr Opin Cardiol 2012,27:273–280.DOI: 10.1097/HCO.0b013e3283512035
19.Vogelsang TW, Jensen RJ, Monrad AL, et al.Independent effects of both right and left ventricular function on plasma brain natriuretic peptide. Eur J Heart Fail 2007; 9: 892–896. DOI: 10.1016/j.ejheart.2007.05.015
20.Mariano-Goulart D, Eberlé MC, Boudousq V, et al.Major increase in brain natriuretic peptide indicates right ventricular systolic dysfunction in patients with heart failure. Eur J Heart Fail 2003; 5: 481–488. DOI: 10.1016/s1388-9842(03)00041-2
21.Bistola V, Parissis JT, Paraskevaidis I, et al.Prognostic value of tissue Doppler right ventricular systolic and diastolic dysfunction indexes combined with plasma B type natriuretic peptide in patients with advanced heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2010; 105: 249-254.
DOI:10.1016/j.amjcard.2009.08.682
22.Meyer P, Desai R, Mujib M, et al.Right ventricular ejection is an independent predictor of mortality but not of hospitalization in older systolic heart failure patients. Int J Cardiol. 2012;155(1):120–125. DOI: 10.1016/j.ijcard.2011.05.046